FDA Inspection 1211050 — GlaxoSmithKline, LLC.
The FDA completed an inspection of GlaxoSmithKline, LLC. on June 20, 2023 in Conshohocken, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Conshohocken, PA (United States)